sepharose and Lung-Diseases

sepharose has been researched along with Lung-Diseases* in 3 studies

Other Studies

3 other study(ies) available for sepharose and Lung-Diseases

ArticleYear
Synthesis of complement by alveolar macrophages from patients with sarcoidosis.
    Scandinavian journal of immunology, 1990, Volume: 31, Issue:1

    Sarcoidosis is a granulomatous disorder of unknown aetiology. Alveolar macrophages (AM) in sarcoidosis release a variety of mediators important to the pathogenesis of the disease. Complement is essential for the inflammatory response and we investigated whether there were any major defects in the potential for sarcoidosis AM to synthesize complement in vitro. AM from 11 patients with active sarcoidosis and three healthy controls were cultured under serum-free conditions. There was a significant binding of polyclonal (anti-C5, -C6, -C7, -C8) and monoclonal anti-complement antibodies (anti-C3c and anti-C9 neoepitope (aE11] to agarose beads incubated with unstimulated AM for 24, 48, or 72 h. A significant and inhibitable production of soluble C3c, C5, C9, and S-protein was found in the harvested medium as detected by enzyme immunoassays. Activated C3 and C9 were also detected based on neoepitope expression. Presence of co-cultured agarose beads reduced the amount of soluble S-protein due to deposition on the agarose. We argue that the C9 neoepitope is an integral part of the terminal complement complex (TCC), both in the fluid and solid phase when bound to the agarose. In the fluid phase, SC5b-9 was generated, whereas the agarose-bound S-protein is assumed not to be associated with TCC on the beads. The results demonstrate for the first time that AM from sarcoidosis patients synthesize the functional alternative and terminal pathway of complement.

    Topics: Adult; Antibodies, Monoclonal; Antibody Specificity; Blotting, Western; Cells, Cultured; Complement C3; Complement C5; Complement C9; Complement System Proteins; Epitopes; Female; Humans; Lung Diseases; Macrophages; Male; Membrane Glycoproteins; Middle Aged; Pulmonary Alveoli; Sarcoidosis; Sepharose; Vitronectin

1990
Role of interleukin 1 in experimental pulmonary granuloma in mice.
    Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:1

    Pulmonary granulomas were induced in immunized BALB/c mice by the intratracheal injection of antigen-coated and plain agarose beads. Prominent lesions developed within 24 hr, reached peak intensity within 3 days, and gradually declined in size thereafter. The hypersensitivity granulomas induced in sensitized mice by antigen-coated beads were much larger than the lesions induced by plain beads. Minimal inflammation was produced in unsensitized mice injected with antigen-coated or plain beads. Aqueous extracts prepared from pulmonary granuloma lesions induced in sensitized mice by antigen-coated beads contained high levels of interleukin 1 (IL 1) and migration inhibition factor (MIF) activities. The kinetics of appearance of these mediators were similar. Lower but detectable activity of both mediators was detected in extracts prepared from sensitized mice injected with plain beads. Neither interleukin 2 (IL 2) nor IL 2 neutralizing activities were detected in the extracts. The presence of IL 1 and MIF in extracts prepared from early and peak pulmonary granulomatous lesions suggests that these soluble factors are produced by cells within the lesions, and that they are involved in mediating the expression and/or maintenance of the granulomas.

    Topics: Animals; Antigens; Female; Granuloma; Interleukin-1; Leukocyte Migration-Inhibitory Factors; Lung Diseases; Mice; Mice, Inbred BALB C; Sepharose

1985
The pulmonary inflammatory response. Cellular events in experimental pulmonary arterial hypersensitivity disease.
    The American journal of pathology, 1975, Volume: 79, Issue:1

    Horseradish peroxidase (HRP) or bovine serum albumin (BSA) were covalently linked to polyacrylamide or agarose beads and were injected into control Syrian hamsters and hamsters previously immunized with either HRP or BSA. Animals sensitized to soluble antigen and subsequently challenged intravenously with the same antigen immobilized on beads developed an acute focal inflammatory response within 2 to 6 hours after injection. The acute response involved local deposition of IgG and complement (beta1A/beta1C globulin), polymorphonuclear leukocyte exudation, and variable amounts of hemorrhage. A focal vasculitis was occasionally present. Within 72 hours the reaction had become largely mononuclear or granulomatous in nature, and giant cell formation was seen within 4 days after immobilized antigen injection. Severe reactions developed only upon recognition of specific antigenic determinants; thus hamsters immunized against soluble HRP developed characteristic lesions only upon intravenous challenge with HRP-coated beads but not with beads coated with unrelated antigen (BSA). The beads elicited only a mild foreign body reaction in the control hamsters at 5 to 7 days after injection which was temporally and histopathologically distinct from the lesions in immunized hamsters. Thus, the state of existing immunity can influence the character and severity of the local pulmonary inflammatory response.

    Topics: Acrylamides; Animals; Complement System Proteins; Cricetinae; Fluorescent Antibody Technique; Foreign-Body Reaction; Hypersensitivity; Immunoglobulin G; Inflammation; Injections, Intramuscular; Injections, Intravenous; Leukocytes; Lung; Lung Diseases; Microspheres; Peroxidases; Pulmonary Artery; Sepharose; Serum Albumin, Bovine

1975